Literature DB >> 25539587

Time to reconsider how we do antibiotic therapy trials.

Tobias Welte1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25539587     DOI： 10.1016/S1473-3099(14)71063-1

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  2 in total

Review 1.  [Antibiotic Stewardship 2.0. Individualization of therapy].

Authors:  M W Pletz; E Tacconelli; T Welte
Journal:  Internist (Berl)       Date:  2017-07       Impact factor: 0.743

2.  [Infectiology in intensive care medicine].

Authors:  T Welte; K-F Bodmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-04       Impact factor: 0.840
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.